News & Updates
Showing Infectious Diseases articles
Showing
Show Multimedia Only

Fluvoxamine wins, metformin disappoints in long COVID fatigue
a day ago
byElvira Manzano
The antidepressant fluvoxamine reduces long COVID fatigue, whereas the antidiabetic agent metformin fails to outperform placebo in the randomized REVIVE-TOGETHER trial.
Fluvoxamine wins, metformin disappoints in long COVID fatigue
a day ago
COVID-19 vaccine improves survival outcomes in cancer patients on ICI therapy
17 Jun 2026
byStephen Padilla
Vaccination against COVID-19 provides survival benefits to cancer patients receiving immune checkpoint inhibitors (ICIs), as shown in a recent study.







